Lung cancer drug combo trial halted midway – what we know
NCT ID NCT03520686
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called nogapendekin alfa inbakicept combined with standard treatments for people with advanced or metastatic non-small cell lung cancer. The trial was stopped early, so results are limited. It involved 102 adults who had not received prior chemotherapy for their advanced disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Adventist Health Glendale
Glendale, California, 92106, United States
-
Adventist Health White Memorial
Los Angeles, California, 90033, United States
-
Alaska Urological Institute - Alaska Clinical Research Center
Anchorage, Alaska, 99503, United States
-
Astera Cancer Care
East Brunswick, New Jersey, 08816, United States
-
Avera Cancer Institute
Sioux Falls, South Dakota, 57105, United States
-
Baptist Cancer Center
Memphis, Tennessee, 38120, United States
-
Baptist Health - Lexington
Lexington, Kentucky, 40503, United States
-
Baptist Health Louisville
Louisville, Kentucky, 40503, United States
-
Baptist Health South Florida - Miami Cancer Institute
Miami, Florida, 33176, United States
-
Bon Secours Richmond
Richmond, Virginia, 23114, United States
-
Chan Soon-Shiong Institute for Medicine
El Segundo, California, 90245, United States
-
Desert Hematology Oncology Medical Group
Rancho Mirage, California, 92270, United States
-
Genesis Cancer Center
Hot Springs, Arkansas, 71913, United States
-
Gettysburg Cancer Center
Gettysburg, Pennsylvania, 17325, United States
-
Healthcare Research Network
Tinley Park, Illinois, 60487, United States
-
Hoag Memorial Hospital
Newport Beach, California, 92663, United States
-
Karmanos Cancer Center
Detroit, Michigan, 48201, United States
-
LeHigh Valley
Allentown, Pennsylvania, 18103, United States
-
Medical University of South Carolina (MUSC) - Hollings Cancer Center (HCC)
Charleston, South Carolina, 29425, United States
-
Memorial Healthcare
Hollywood, Florida, 33021, United States
-
MemorialCare Health System
Long Beach, California, 90806, United States
-
Mercy Research Joplin
Joplin, Missouri, 64804, United States
-
Mercy Research Oklahoma City
Oklahoma City, Oklahoma, 73120, United States
-
Oncology Consultants, PA
Houston, Texas, 77030, United States
-
Saint Francis Cancer Center/Bon Secours St. Francis Health System
Greenville, South Carolina, 29607, United States
-
St. Vincent Frontier Cancer Center
Billings, Montana, 59102, United States
-
Stony Brooke Medicine
Stony Brook, New York, 11794, United States
-
Texas Oncology-Austin
Austin, Texas, 78745, United States
-
Texas Oncology-Bedford
Bedford, Texas, 76002, United States
-
University of Rochester
Rochester, New York, 14642, United States
-
University of Tennessee Medical Center
Knoxville, Tennessee, 37920, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?